Hikma Pharmaceuticals PLC Strategic Asset Allocation Index
Hikma Pharmaceuticals PLC strategic asset allocation index. Hikma Pharmaceuticals PLC (HIK) has a Strategic Asset Allocation Index of 49.4% as of June 2023. Strategic assets (PP&E of GBX1.09 Billion plus long-term investments of GBX-) total GBX1.09 Billion, measured against net assets of GBX2.20 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Hikma Pharmaceuticals PLC to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Hikma Pharmaceuticals PLC (2004–2022)
Strategic asset allocation index of Hikma Pharmaceuticals PLC from 2004 to 2022. This chart shows how Hikma Pharmaceuticals PLC's Strategic Asset Allocation Index has evolved across 19 annual periods from 2004 to 2022. As of June 2023, the index stands at 49.4%, representing strategic assets of GBX1.09 Billion against net assets of GBX2.20 Billion GBX.
Hikma Pharmaceuticals PLC Strategic Asset Allocation Index by Year (2004–2022)
Hikma Pharmaceuticals PLC strategic asset allocation index by year from 2004 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Hikma Pharmaceuticals PLC from 2004 to 2022, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hikma Pharmaceuticals PLC stock valuation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 50.3% | GBX1.08 Billion | GBX1.08 Billion | GBX- | GBX2.15 Billion | ▲ +3.9 pp |
| 2021 | 46.5% | GBX1.15 Billion | GBX1.15 Billion | GBX- | GBX2.47 Billion | ▼ -3.3 pp |
| 2020 | 49.7% | GBX1.07 Billion | GBX1.07 Billion | GBX- | GBX2.15 Billion | ▲ +2.5 pp |
| 2019 | 47.2% | GBX1.00 Billion | GBX962.00 Million | GBX43.00 Million | GBX2.13 Billion | ▼ -6.3 pp |
| 2018 | 53.5% | GBX908.00 Million | GBX870.00 Million | GBX38.00 Million | GBX1.70 Billion | ▼ -2.1 pp |
| 2017 | 55.6% | GBX850.00 Million | GBX828.00 Million | GBX22.00 Million | GBX1.53 Billion | ▲ +14.9 pp |
| 2016 | 40.8% | GBX983.00 Million | GBX969.00 Million | GBX14.00 Million | GBX2.41 Billion | ▲ +2.6 pp |
| 2015 | 38.2% | GBX516.00 Million | GBX507.00 Million | GBX9.00 Million | GBX1.35 Billion | ▼ -5.6 pp |
| 2014 | 43.8% | GBX532.00 Million | GBX514.00 Million | GBX18.00 Million | GBX1.22 Billion | ▼ -1.4 pp |
| 2013 | 45.2% | GBX467.00 Million | GBX443.00 Million | GBX24.00 Million | GBX1.03 Billion | ▼ -4.4 pp |
| 2012 | 49.5% | GBX419.94 Million | GBX419.94 Million | GBX- | GBX847.85 Million | ▼ -3.2 pp |
| 2011 | 52.8% | GBX421.36 Million | GBX421.36 Million | GBX- | GBX798.63 Million | ▲ +10.4 pp |
| 2010 | 42.3% | GBX317.46 Million | GBX317.46 Million | GBX- | GBX750.30 Million | ▲ +0.8 pp |
| 2009 | 41.5% | GBX283.37 Million | GBX283.37 Million | GBX- | GBX683.26 Million | ▼ -3.1 pp |
| 2008 | 44.6% | GBX271.65 Million | GBX271.65 Million | GBX- | GBX609.00 Million | ▼ -12.8 pp |
| 2007 | 57.4% | GBX243.90 Million | GBX243.90 Million | GBX- | GBX424.66 Million | ▲ +12.6 pp |
| 2006 | 44.8% | GBX156.84 Million | GBX156.84 Million | GBX- | GBX349.80 Million | ▲ +13.1 pp |
| 2005 | 31.7% | GBX91.21 Million | GBX91.21 Million | GBX- | GBX287.48 Million | ▼ -17.5 pp |
| 2004 | 49.2% | GBX71.47 Million | GBX71.47 Million | GBX- | GBX145.18 Million | — |